AIM ImmunoTech Inc. — Director's Dealing 2013

Aug 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2013-08-02

Reporting Person: CARTER WILLIAM A (Director, CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-02	Options to buy Common Stock	$0.25	J	150000	Acquired	2023-08-02	Common Stock (150000)	Direct

Footnotes

F1: Stock Options issued as a result of a Board resolution to grant 150,000 shares to each member of the Board of Directors.